Breaking News Instant updates and real-time market news.

AVXL

Anavex

$8.85 /

+0.03 (+0.34%)

20:30
12/01/22
12/01
20:30
12/01/22
20:30

Anavex phase 2B/3 study of blarcamesine met primary and key secondary endpoints

Anavex Life Sciences "announced positive topline results from its Phase 2b/3 ANAVEX(R)2-73-AD-004 clinical trial of oral ANAVEX2-73, or blarcamesine, for the treatment of mild cognitive impairment due to Alzheimer's disease, AD, and mild AD . ANAVEX(R)2-73 met the primary endpoints ADAS-Cog1 and ADCS-ADL2 and key secondary endpoint CDR-SB3 with statistically significant results. Next step, in light of this data, is meeting with regulatory authorities to discuss this data in the context of ongoing development with an aim to bring this therapy to patients in Europe, Asia-Pacific, and the U.S."

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
Cathie Wood's ARK Investment bought 424.7K shares of Cerus today  20:31
03/20/23
03/20
20:31
03/20/23
20:31
CERS

Cerus

$2.90 /

-0.02 (-0.68%)

 
ShowHide Related Items >><<
CERS Cerus
$2.90 /

-0.02 (-0.68%)

CERS Cerus
$2.90 /

-0.02 (-0.68%)

01/20/23 BTIG
Cerus downgraded to Neutral from Buy at BTIG
CERS Cerus
$2.90 /

-0.02 (-0.68%)

CERS Cerus
$2.90 /

-0.02 (-0.68%)

Hot Stocks
Cathie Wood's ARK Investment bought 41K shares of Microsoft today  20:30
03/20/23
03/20
20:30
03/20/23
20:30
MSFT

Microsoft

$272.20 /

-7.21 (-2.58%)

 
ShowHide Related Items >><<
MSFT Microsoft
$272.20 /

-7.21 (-2.58%)

MSFT Microsoft
$272.20 /

-7.21 (-2.58%)

16:12 Today Stifel
Alphabet resumed with a Buy at Stifel
06:19 Today Evercore ISI
Microsoft price target raised to $295 from $280 at Evercore ISI
03/17/23 Mizuho
Microsoft price target raised to $315 from $300 at Mizuho
03/16/23 Macquarie
Microsoft 'clear winner' in ongoing generative AI fight, says Macquarie
MSFT Microsoft
$272.20 /

-7.21 (-2.58%)

MSFT Microsoft
$272.20 /

-7.21 (-2.58%)

MSFT Microsoft
$272.20 /

-7.21 (-2.58%)

MSFT Microsoft
$272.20 /

-7.21 (-2.58%)

Hot Stocks
Cathie Wood's ARK Investment bought 181K shares of Teladoc today  20:30
03/20/23
03/20
20:30
03/20/23
20:30
TDOC

Teladoc

$24.37 /

-0.185 (-0.75%)

 
ShowHide Related Items >><<
TDOC Teladoc
$24.37 /

-0.185 (-0.75%)

TDOC Teladoc
$24.37 /

-0.185 (-0.75%)

03/10/23 Credit Suisse
Teladoc price target lowered to $27 from $30 at Credit Suisse
03/06/23 Canaccord
Teladoc price target lowered to $36 from $40 at Canaccord
03/06/23 Wells Fargo
Teladoc price target lowered to $23 from $28 at Wells Fargo
02/27/23 Deutsche Bank
Teladoc price target lowered to $27 from $31 at Deutsche Bank
TDOC Teladoc
$24.37 /

-0.185 (-0.75%)

TDOC Teladoc
$24.37 /

-0.185 (-0.75%)

TDOC Teladoc
$24.37 /

-0.185 (-0.75%)

TDOC Teladoc
$24.37 /

-0.185 (-0.75%)

Hot Stocks
Enovix director buys $757K in common stock » 20:28
03/20/23
03/20
20:28
03/20/23
20:28
ENVX

Enovix

$10.83 /

-0.4 (-3.56%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ENVX Enovix
$10.83 /

-0.4 (-3.56%)

ENVX Enovix
$10.83 /

-0.4 (-3.56%)

02/23/23 Craig-Hallum
Enovix price target lowered to $15 from $23 at Craig-Hallum
02/23/23 Piper Sandler
Enovix price target raised to $25 from $22.50 at Piper Sandler
01/26/23 JPMorgan
Enovix price target lowered to $16 from $28 at JPMorgan
01/23/23 Piper Sandler
Enovix price target lowered to $22.50 from $26.50 at Piper Sandler
ENVX Enovix
$10.83 /

-0.4 (-3.56%)

ENVX Enovix
$10.83 /

-0.4 (-3.56%)

ENVX Enovix
$10.83 /

-0.4 (-3.56%)

Hot Stocks
Snap COO sells $763.9K in common stock » 19:09
03/20/23
03/20
19:09
03/20/23
19:09
SNAP

Snap

$10.65 /

-0.045 (-0.42%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNAP Snap
$10.65 /

-0.045 (-0.42%)

SNAP Snap
$10.65 /

-0.045 (-0.42%)

03/16/23 Benchmark
Benchmark sees low odds of any formal TikTok ban in U.S. through 2024
03/09/23 Piper Sandler
Piper says TikTok ownership change would have negligible value impact on peers
02/14/23 BofA
Snap analyst day an opportunity to reset targets, says BofA
02/01/23 Truist
Snap price target lowered to $8 from $10 at Truist
SNAP Snap
$10.65 /

-0.045 (-0.42%)

SNAP Snap
$10.65 /

-0.045 (-0.42%)

SNAP Snap
$10.65 /

-0.045 (-0.42%)

SNAP Snap
$10.65 /

-0.045 (-0.42%)

Hot Stocks
Snap CFO sells $539K in common stock » 19:08
03/20/23
03/20
19:08
03/20/23
19:08
SNAP

Snap

$10.65 /

-0.045 (-0.42%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNAP Snap
$10.65 /

-0.045 (-0.42%)

SNAP Snap
$10.65 /

-0.045 (-0.42%)

03/16/23 Benchmark
Benchmark sees low odds of any formal TikTok ban in U.S. through 2024
03/09/23 Piper Sandler
Piper says TikTok ownership change would have negligible value impact on peers
02/14/23 BofA
Snap analyst day an opportunity to reset targets, says BofA
02/01/23 Truist
Snap price target lowered to $8 from $10 at Truist
SNAP Snap
$10.65 /

-0.045 (-0.42%)

SNAP Snap
$10.65 /

-0.045 (-0.42%)

SNAP Snap
$10.65 /

-0.045 (-0.42%)

SNAP Snap
$10.65 /

-0.045 (-0.42%)

Recommendations
Pinduoduo price target lowered to $115 from $127 at Citi » 18:50
03/20/23
03/20
18:50
03/20/23
18:50
PDD

Pinduoduo

$78.90 /

-13.01 (-14.16%)

Citi lowered the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PDD Pinduoduo
$78.90 /

-13.01 (-14.16%)

PDD Pinduoduo
$78.90 /

-13.01 (-14.16%)

03/02/23 Morgan Stanley
Pinduoduo upgraded to Overweight from Equal Weight at Morgan Stanley
12/09/22 KGI Securities
Pinduoduo upgraded to Outperform from Neutral at KGI Securities
11/30/22 Barclays
Pinduoduo price target raised to $84 from $70 at Barclays
11/29/22 Benchmark
Pinduoduo price target raised to $112 from $107 at Benchmark
PDD Pinduoduo
$78.90 /

-13.01 (-14.16%)

PDD Pinduoduo
$78.90 /

-13.01 (-14.16%)

PDD Pinduoduo
$78.90 /

-13.01 (-14.16%)

PDD Pinduoduo
$78.90 /

-13.01 (-14.16%)

Recommendations
MacroGenics price target raised to $12 from $6 at BTIG » 18:47
03/20/23
03/20
18:47
03/20/23
18:47
MGNX

MacroGenics

$6.70 /

+0.05 (+0.75%)

BTIG analyst Kaveri…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MGNX MacroGenics
$6.70 /

+0.05 (+0.75%)

MGNX MacroGenics
$6.70 /

+0.05 (+0.75%)

06:47 Today Citi
MacroGenics price target raised to $8 from $7 at Citi
06:14 Today H.C. Wainwright
MacroGenics price target raised to $14 from $12 at H.C. Wainwright
03/17/23 Guggenheim
MacroGenics downgraded to Neutral at Guggenheim on prostate cancer caution
03/17/23 Guggenheim
MacroGenics downgraded to Neutral from Buy at Guggenheim
MGNX MacroGenics
$6.70 /

+0.05 (+0.75%)

MGNX MacroGenics
$6.70 /

+0.05 (+0.75%)

Recommendations
WeWork price target lowered to $3 from $7.50 at BTIG » 18:46
03/20/23
03/20
18:46
03/20/23
18:46
WE

WeWork

$1.01 /

+0.0348 (+3.57%)

BTIG analyst Thomas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WE WeWork
$1.01 /

+0.0348 (+3.57%)

WE WeWork
$1.01 /

+0.0348 (+3.57%)

02/16/23 Piper Sandler
WeWork shares should outperform on results, says Piper Sandler
01/03/23 BTIG
WeWork named Top Pick for first half of 2023 at BTIG
12/21/22 Cantor Fitzgerald
WeWork weakness an attractive buying opportunity, says Cantor Fitzgerald
11/04/22 BTIG
WeWork initiated with a Buy at BTIG
WE WeWork
$1.01 /

+0.0348 (+3.57%)

WE WeWork
$1.01 /

+0.0348 (+3.57%)

WE WeWork
$1.01 /

+0.0348 (+3.57%)

WE WeWork
$1.01 /

+0.0348 (+3.57%)

Periodicals
Judge says JPMorgan, Deutsche will have to face Epstein lawsuits, Reuters says » 18:29
03/20/23
03/20
18:29
03/20/23
18:29
JPM

JPMorgan

$127.09 /

+1.32 (+1.05%)

, DB

Deutsche Bank

$9.92 /

+0.03 (+0.30%)

U.S. District Judge Jed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JPM JPMorgan
$127.09 /

+1.32 (+1.05%)

DB Deutsche Bank
$9.92 /

+0.03 (+0.30%)

JPM JPMorgan
$127.09 /

+1.32 (+1.05%)

03/13/23 Wells Fargo
Wells Fargo upgrades JPMorgan on 'Goliath is Winning' theme
03/13/23 Wells Fargo
JPMorgan upgraded to Overweight from Equal Weight at Wells Fargo
02/24/23 Morgan Stanley
JPMorgan price target raised to $173 from $167 at Morgan Stanley
02/08/23 Keefe Bruyette
Keefe Bruyette downgrades 'vulnerable' Bank of America to Underperform
DB Deutsche Bank
$9.92 /

+0.03 (+0.30%)

02/10/23 BofA
Deutsche Bank downgraded to Underperform from Neutral at BofA
02/08/23 UBS
Deutsche Bank price target raised to EUR 18.80 from EUR 16.30 at UBS
02/03/23 Credit Suisse
Deutsche Bank price target raised to EUR 11 from EUR 10.50 at Credit Suisse
01/13/23 Barclays
Deutsche Bank price target raised to EUR 12.50 from EUR 11.50 at Barclays
JPM JPMorgan
$127.09 /

+1.32 (+1.05%)

DB Deutsche Bank
$9.92 /

+0.03 (+0.30%)

JPM JPMorgan
$127.09 /

+1.32 (+1.05%)

DB Deutsche Bank
$9.92 /

+0.03 (+0.30%)

JPM JPMorgan
$127.09 /

+1.32 (+1.05%)

DB Deutsche Bank
$9.92 /

+0.03 (+0.30%)

JPM JPMorgan
$127.09 /

+1.32 (+1.05%)

DB Deutsche Bank
$9.92 /

+0.03 (+0.30%)

Hot Stocks
Broadcom CEO sells $18.8M in common stock » 18:26
03/20/23
03/20
18:26
03/20/23
18:26
AVGO

Broadcom

$643.63 /

+13.22 (+2.10%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVGO Broadcom
$643.63 /

+13.22 (+2.10%)

AVGO Broadcom
$643.63 /

+13.22 (+2.10%)

03/03/23 OTR Global
Qualcomm displacing Broadcom for S23 components, says OTR Global
03/03/23 Truist
Broadcom price target raised to $700 from $659 at Truist
03/03/23 Susquehanna
Broadcom price target raised to $690 from $685 at Susquehanna
03/03/23 TD Cowen
Broadcom price target raised to $615 from $540 at TD Cowen
AVGO Broadcom
$643.63 /

+13.22 (+2.10%)

AVGO Broadcom
$643.63 /

+13.22 (+2.10%)

AVGO Broadcom
$643.63 /

+13.22 (+2.10%)

AVGO Broadcom
$643.63 /

+13.22 (+2.10%)

Hot Stocks
First Majestic falls 17% after announcing cost cuts, suspended mining activity  18:25
03/20/23
03/20
18:25
03/20/23
18:25
AG

First Majestic

$7.44 /

+0.12 (+1.64%)

 
ShowHide Related Items >><<
AG First Majestic
$7.44 /

+0.12 (+1.64%)

AG First Majestic
$7.44 /

+0.12 (+1.64%)

02/27/23 TD Securities
First Majestic price target lowered to C$11 from C$12 at TD Securities
02/14/23 National Bank
First Majestic price target lowered to C$11 from C$14.50 at National Bank
01/20/23 BMO Capital
First Majestic price target lowered to C$9 from C$10.50 at BMO Capital
01/13/23 National Bank
First Majestic price target raised to C$14.50 from C$13 at National Bank
AG First Majestic
$7.44 /

+0.12 (+1.64%)

Hot Stocks
RA Capital reports 9.99% passive stake in Orchard Therapeutics » 18:22
03/20/23
03/20
18:22
03/20/23
18:22
ORTX

Orchard Therapeutics

$4.76 /

+0.16 (+3.48%)

RA Capital disclosed a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ORTX Orchard Therapeutics
$4.76 /

+0.16 (+3.48%)

ORTX Orchard Therapeutics
$4.76 /

+0.16 (+3.48%)

03/15/23 Stifel
Orchard Therapeutics target adjusted to $22 at Stifel after ADS ratio change
03/13/23 Oppenheimer
Orchard Therapeutics price target raised to $37 from $5 at Oppenheimer
07/18/22 Oppenheimer
Orchard Therapeutics assumed with an Outperform at Oppenheimer
05/13/22 Barclays
Orchard Therapeutics price target lowered to $4 from $6 at Barclays
ORTX Orchard Therapeutics
$4.76 /

+0.16 (+3.48%)

ORTX Orchard Therapeutics
$4.76 /

+0.16 (+3.48%)

Hot Stocks
Canadian National, Unifor reach tentative agreements » 18:02
03/20/23
03/20
18:02
03/20/23
18:02
CNI

Canadian National

$115.34 /

+0.1 (+0.09%)

Canadian National…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNI Canadian National
$115.34 /

+0.1 (+0.09%)

CNI Canadian National
$115.34 /

+0.1 (+0.09%)

01/25/23 Desjardins
Canadian National price target lowered to C$179 from C$180 at Desjardins
01/25/23 CIBC
Canadian National price target lowered to C$175 from C$181 at CIBC
01/25/23 BMO Capital
Canadian National price target lowered to C$180 from C$185 at BMO Capital
01/25/23 Scotiabank
Canadian National price target lowered to C$167 from C$170 at Scotiabank
CNI Canadian National
$115.34 /

+0.1 (+0.09%)

CNI Canadian National
$115.34 /

+0.1 (+0.09%)

CNI Canadian National
$115.34 /

+0.1 (+0.09%)

Periodicals
Thermo Fisher, Celltrion compete for Baxter's biopharma unit, Reuters says » 18:02
03/20/23
03/20
18:02
03/20/23
18:02
TMO

Thermo Fisher

$550.60 /

+3.39 (+0.62%)

, BAX

Baxter

$38.22 /

+0.64 (+1.70%)

, KKR

KKR

$48.63 /

+0.175 (+0.36%)

, CG

Carlyle Group

$30.29 /

-0.14 (-0.46%)

The biopharma solutions…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TMO Thermo Fisher
$550.60 /

+3.39 (+0.62%)

KKR KKR
$48.63 /

+0.175 (+0.36%)

CG Carlyle Group
$30.29 /

-0.14 (-0.46%)

BAX Baxter
$38.22 /

+0.64 (+1.70%)

TMO Thermo Fisher
$550.60 /

+3.39 (+0.62%)

03/10/23 Chardan
Gensight Biologics price target lowered to EUR 13 from EUR 15 at Chardan
02/06/23 Jefferies
Jefferies says Catalent could be valued near $93 on average CDMO buyout multiple
02/02/23 Morgan Stanley
Thermo Fisher price target raised to $670 from $613 at Morgan Stanley
02/02/23 TD Cowen
Thermo Fisher price target raised to $711 from $690 at Cowen
BAX Baxter
$38.22 /

+0.64 (+1.70%)

02/13/23 Barclays
Baxter price target lowered to $54 from $63 at Barclays
02/10/23 TD Cowen
Baxter price target lowered to $45 from $70 at Cowen
02/06/23 KeyBanc
Baxter price target lowered to $60 from $73 at KeyBanc
02/01/23 Piper Sandler
Miromatrix MiroliverELAP timeline pushed out two or three quarters, says Piper
KKR KKR
$48.63 /

+0.175 (+0.36%)

03/02/23 Barclays
KKR initiated with an Overweight at Barclays
02/08/23 Deutsche Bank
KKR price target raised to $70 from $67 at Deutsche Bank
02/08/23 Wells Fargo
KKR price target raised to $65 from $59 at Wells Fargo
02/08/23 JMP Securities
KKR price target raised to $80 from $72 at JMP Securities
CG Carlyle Group
$30.29 /

-0.14 (-0.46%)

03/02/23 Barclays
Carlyle Group initiated with an Overweight at Barclays
02/08/23 Deutsche Bank
Carlyle Group price target raised to $43 from $41 at Deutsche Bank
02/08/23 Piper Sandler
Carlyle Group price target lowered to $48 from $58 at Piper Sandler
01/31/23 BMO Capital
Franklin Resources price target raised to $23 from $22 at BMO Capital
TMO Thermo Fisher
$550.60 /

+3.39 (+0.62%)

KKR KKR
$48.63 /

+0.175 (+0.36%)

CG Carlyle Group
$30.29 /

-0.14 (-0.46%)

BAX Baxter
$38.22 /

+0.64 (+1.70%)

TMO Thermo Fisher
$550.60 /

+3.39 (+0.62%)

KKR KKR
$48.63 /

+0.175 (+0.36%)

CG Carlyle Group
$30.29 /

-0.14 (-0.46%)

TMO Thermo Fisher
$550.60 /

+3.39 (+0.62%)

KKR KKR
$48.63 /

+0.175 (+0.36%)

CG Carlyle Group
$30.29 /

-0.14 (-0.46%)

BAX Baxter
$38.22 /

+0.64 (+1.70%)

TMO Thermo Fisher
$550.60 /

+3.39 (+0.62%)

KKR KKR
$48.63 /

+0.175 (+0.36%)

BAX Baxter
$38.22 /

+0.64 (+1.70%)

On The Fly
Fly Intel: After-Hours Movers » 17:59
03/20/23
03/20
17:59
03/20/23
17:59
LTRN

Lantern Pharma

$4.62 /

-0.045 (-0.97%)

, HLIT

Harmonic

$13.11 /

+0.72 (+5.81%)

, PET

Wag! Group

$1.86 /

-0.19 (-9.27%)

, NNDM

Nano Dimension

$2.58 /

-0.03 (-1.15%)

, FUSN

Fusion Pharmaceuticals

$4.00 /

-0.05 (-1.23%)

, VTYX

Ventyx Biosciences

$37.83 /

+1.175 (+3.21%)

Check out this evening's…

ShowHide Related Items >><<
VTYX Ventyx Biosciences
$37.83 /

+1.175 (+3.21%)

PET Wag! Group
$1.86 /

-0.19 (-9.27%)

NNDM Nano Dimension
$2.58 /

-0.03 (-1.15%)

LTRN Lantern Pharma
$4.62 /

-0.045 (-0.97%)

HLIT Harmonic
$13.11 /

+0.72 (+5.81%)

FUSN Fusion Pharmaceuticals
$4.00 /

-0.05 (-1.23%)

LTRN Lantern Pharma
$4.62 /

-0.045 (-0.97%)

10/31/22 EF Hutton
Lantern Pharma initiated with a Buy at EF Hutton
HLIT Harmonic
$13.11 /

+0.72 (+5.81%)

02/08/23 Jefferies
Jefferies reveals top broadband plays, sees 5 years of strong growth
01/31/23 Barclays
Harmonic price target raised to $20 from $17 at Barclays
01/09/23 Jefferies
Harmonic upgraded to Buy from Hold at Jefferies
01/09/23 Jefferies
Harmonic upgraded to Buy from Hold at Jefferies
PET Wag! Group
$1.86 /

-0.19 (-9.27%)

11/21/22 Oppenheimer
Wag! Group initiated with an Outperform at Oppenheimer
11/14/22 DA Davidson
Wag! Group price target lowered to $6.50 from $11 at DA Davidson
10/17/22 Roth MKM
Wag! Group initiated with a Buy at Roth Capital
10/14/22 Craig-Hallum
Wag! Group initiated with a Buy at Craig-Hallum
NNDM Nano Dimension
$2.58 /

-0.03 (-1.15%)

03/10/23 Lake Street
Nano Dimension made 'lowball offer' Stratasys won't accept, says Lake Street
FUSN Fusion Pharmaceuticals
$4.00 /

-0.05 (-1.23%)

12/01/22 B. Riley
Fusion Pharmaceuticals resumed with a Buy at B. Riley
11/30/22 SVB Securities
Fusion Pharmaceuticals initiated with an Outperform at SVB Securities
09/15/22 Truist
Truist starts Fusion Pharmaceuticals at Buy with $10 price target
09/15/22 Truist
Fusion Pharmaceuticals initiated with a Buy at Truist
VTYX Ventyx Biosciences
$37.83 /

+1.175 (+3.21%)

16:28 Today Wells Fargo
Wells starts Ventyx at Overweight, sees multiple catalysts in next 12-18 months
16:05 Today Wells Fargo
Ventyx Biosciences initiated with an Overweight at Wells Fargo
06:24 Today Oppenheimer
Ventyx Biosciences price target raised to $65 from $60 at Oppenheimer
01/31/23 Canaccord
Ventyx Biosciences price target raised to $54 from $35 at Canaccord
VTYX Ventyx Biosciences
$37.83 /

+1.175 (+3.21%)

PET Wag! Group
$1.86 /

-0.19 (-9.27%)

NNDM Nano Dimension
$2.58 /

-0.03 (-1.15%)

LTRN Lantern Pharma
$4.62 /

-0.045 (-0.97%)

HLIT Harmonic
$13.11 /

+0.72 (+5.81%)

FUSN Fusion Pharmaceuticals
$4.00 /

-0.05 (-1.23%)

NNDM Nano Dimension
$2.58 /

-0.03 (-1.15%)

VTYX Ventyx Biosciences
$37.83 /

+1.175 (+3.21%)

PET Wag! Group
$1.86 /

-0.19 (-9.27%)

NNDM Nano Dimension
$2.58 /

-0.03 (-1.15%)

HLIT Harmonic
$13.11 /

+0.72 (+5.81%)

NNDM Nano Dimension
$2.58 /

-0.03 (-1.15%)

Hot Stocks
Moody's upgrades Tesla's credit rating, declares outlook stable » 17:48
03/20/23
03/20
17:48
03/20/23
17:48
TSLA

Tesla

$183.22 /

+3.175 (+1.76%)

Moody's Investors…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$183.22 /

+3.175 (+1.76%)

TSLA Tesla
$183.22 /

+3.175 (+1.76%)

07:50 Today Morgan Stanley
XPeng price target raised to $12.50 from $12 at Morgan Stanley
07:49 Today Morgan Stanley
Li Auto price target raised to $30 from $23 at Morgan Stanley
03/13/23 Wolfe Research
Tesla downgraded to Peer Perform from Outperform at Wolfe Research
03/09/23 Morgan Stanley
Morgan Stanley questions if Tesla has 'outgrown the Cybertruck'
TSLA Tesla
$183.22 /

+3.175 (+1.76%)

TSLA Tesla
$183.22 /

+3.175 (+1.76%)

TSLA Tesla
$183.22 /

+3.175 (+1.76%)

TSLA Tesla
$183.22 /

+3.175 (+1.76%)

Hot Stocks
Charles Schwab director buys $200K in common stock » 17:47
03/20/23
03/20
17:47
03/20/23
17:47
SCHW

Charles Schwab

$56.09 /

-0.28 (-0.50%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCHW Charles Schwab
$56.09 /

-0.28 (-0.50%)

SCHW Charles Schwab
$56.09 /

-0.28 (-0.50%)

03/15/23 Credit Suisse
Charles Schwab upgraded to Outperform from Neutral at Credit Suisse
03/14/23 JPMorgan
Schwab funding concerns 'significantly de-risked,' says JPMorgan
03/14/23 Piper Sandler
Charles Schwab price target lowered to $95 from $100 at Piper Sandler
03/14/23 Deutsche Bank
Charles Schwab price target lowered to $83 from $109 at Deutsche Bank
SCHW Charles Schwab
$56.09 /

-0.28 (-0.50%)

  • 10
    Mar
  • 02
    Aug
SCHW Charles Schwab
$56.09 /

-0.28 (-0.50%)

SCHW Charles Schwab
$56.09 /

-0.28 (-0.50%)

SCHW Charles Schwab
$56.09 /

-0.28 (-0.50%)

Periodicals
Goldman tells Reuters Credit Suisse AT1 move could cut long-term demand » 17:44
03/20/23
03/20
17:44
03/20/23
17:44
GS

Goldman Sachs

$309.52 /

+6.13 (+2.02%)

, CS

Credit Suisse

/

+

Goldman Sachs (GS) chief…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GS Goldman Sachs
$309.52 /

+6.13 (+2.02%)

CS Credit Suisse
/

+

GS Goldman Sachs
$309.52 /

+6.13 (+2.02%)

03/09/23 BofA
Goldman Sachs price target raised to $425 from $384 at BofA
03/02/23 Seaport Global
Goldman remains a top pick at Seaport after investor day
03/01/23 Jefferies
Jefferies keeps Buy on Goldman Sachs, says 'questions remain' after investor day
02/27/23 Morgan Stanley
Morgan Stanley not expecting new return targets at Goldman investor day
CS Credit Suisse
/

+

08:46 Today Barclays
European Banks sector view downgraded to Neutral at Barclays
05:58 Today Societe Generale
UBS downgraded to Hold from Buy at Societe Generale
05:16 Today BofA
UBS upgraded to Buy from Neutral at BofA
03/16/23 JPMorgan
Credit Suisse gets short-term relief, but questions remain, says JPMorgan
GS Goldman Sachs
$309.52 /

+6.13 (+2.02%)

CS Credit Suisse
/

+

GS Goldman Sachs
$309.52 /

+6.13 (+2.02%)

CS Credit Suisse
/

+

GS Goldman Sachs
$309.52 /

+6.13 (+2.02%)

CS Credit Suisse
/

+

GS Goldman Sachs
$309.52 /

+6.13 (+2.02%)

CS Credit Suisse
/

+

Hot Stocks
Sigmatron International discloses Event of Default from on credit agreement » 17:39
03/20/23
03/20
17:39
03/20/23
17:39
SGMA

Sigmatron International

$3.12 /

-0.105 (-3.26%)

In a regulatory 8-K…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SGMA Sigmatron International
$3.12 /

-0.105 (-3.26%)

SGMA Sigmatron International
$3.12 /

-0.105 (-3.26%)

Hot Stocks
OpenAI-powered app from Nuance will instantly transcribe patient notes » 17:37
03/20/23
03/20
17:37
03/20/23
17:37
MSFT

Microsoft

$272.20 /

-7.21 (-2.58%)

Nuance Communications, a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$272.20 /

-7.21 (-2.58%)

MSFT Microsoft
$272.20 /

-7.21 (-2.58%)

16:12 Today Stifel
Alphabet resumed with a Buy at Stifel
06:19 Today Evercore ISI
Microsoft price target raised to $295 from $280 at Evercore ISI
03/17/23 Mizuho
Microsoft price target raised to $315 from $300 at Mizuho
03/16/23 Macquarie
Microsoft 'clear winner' in ongoing generative AI fight, says Macquarie
MSFT Microsoft
$272.20 /

-7.21 (-2.58%)

MSFT Microsoft
$272.20 /

-7.21 (-2.58%)

MSFT Microsoft
$272.20 /

-7.21 (-2.58%)

MSFT Microsoft
$272.20 /

-7.21 (-2.58%)

Conference/Events
Intuit management to meet with Mizuho » 17:37
03/20/23
03/20
17:37
03/20/23
17:37
INTU

Intuit

$411.88 /

-1.54 (-0.37%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INTU Intuit
$411.88 /

-1.54 (-0.37%)

INTU Intuit
$411.88 /

-1.54 (-0.37%)

03/15/23 UBS
Intuit initiated with a Neutral at UBS
03/15/23 Daiwa
Intuit initiated with an Outperform at Daiwa
02/27/23 Citi
Intuit price target raised to $475 from $457 at Citi
02/24/23 BMO Capital
Intuit price target raised to $462 from $448 at BMO Capital
INTU Intuit
$411.88 /

-1.54 (-0.37%)

INTU Intuit
$411.88 /

-1.54 (-0.37%)

INTU Intuit
$411.88 /

-1.54 (-0.37%)

INTU Intuit
$411.88 /

-1.54 (-0.37%)

Conference/Events
Embecta management to meet with Mizuho » 17:34
03/20/23
03/20
17:34
03/20/23
17:34
EMBC

Embecta

$29.67 /

-0.155 (-0.52%)

Meeting to be held on the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EMBC Embecta
$29.67 /

-0.155 (-0.52%)

EMBC Embecta
$29.67 /

-0.155 (-0.52%)

01/06/23 Morgan Stanley
Morgan Stanley cuts 'longer-term execution story' Embecta to Underweight
01/06/23 Morgan Stanley
Embecta downgraded to Underweight from Equal Weight at Morgan Stanley
09/08/22 BTIG
Embecta initiated with a Neutral at BTIG
08/01/22 Morgan Stanley
Embecta initiated with an Equal Weight at Morgan Stanley
EMBC Embecta
$29.67 /

-0.155 (-0.52%)

EMBC Embecta
$29.67 /

-0.155 (-0.52%)

Conference/Events
SoFi Technologies management to meet with Mizuho » 17:33
03/20/23
03/20
17:33
03/20/23
17:33
SOFI

SoFi Technologies

$5.23 /

-0.235 (-4.30%)

Meeting to be held in San…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SOFI SoFi Technologies
$5.23 /

-0.235 (-4.30%)

SOFI SoFi Technologies
$5.23 /

-0.235 (-4.30%)

02/15/23 Mizuho
SoFi Technologies price target raised to $9 from $6 at Mizuho
01/31/23 Citi
SoFi shares remain a buy after 'solid beat,' says Citi
01/31/23 Morgan Stanley
SoFi Technologies price target raised to $6 from $5 at Morgan Stanley
01/31/23 Mizuho
SoFi Technologies beat should drive stock higher, says Mizuho
SOFI SoFi Technologies
$5.23 /

-0.235 (-4.30%)

  • 24
    Aug
SOFI SoFi Technologies
$5.23 /

-0.235 (-4.30%)

SOFI SoFi Technologies
$5.23 /

-0.235 (-4.30%)

SOFI SoFi Technologies
$5.23 /

-0.235 (-4.30%)

Hot Stocks
Ferrari announces cybersecurity incident » 17:32
03/20/23
03/20
17:32
03/20/23
17:32
RACE

Ferrari

$262.54 /

+3.24 (+1.25%)

"Ferrari N.V…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RACE Ferrari
$262.54 /

+3.24 (+1.25%)

RACE Ferrari
$262.54 /

+3.24 (+1.25%)

03/06/23 Morgan Stanley
Ferrari replaces Tesla as Morgan Stanley top pick in autos
02/06/23 RBC Capital
Ferrari price target raised to EUR 283 from EUR 265 at RBC Capital
02/03/23 UBS
Ferrari price target raised to $330 from $274 at UBS
02/03/23 Credit Suisse
Ferrari price target raised to $310 from $290 at Credit Suisse
RACE Ferrari
$262.54 /

+3.24 (+1.25%)

RACE Ferrari
$262.54 /

+3.24 (+1.25%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.